Major Stake Sale Consummated: Novonor Transfers 34.3% Braskem Stake to Shine I Fund, Triggering Tender Offer
Summary
Braskem announced the consummation of Novonor's sale of a 34.3% stake to Shine I Fund, establishing new control and triggering a mandatory tender offer for all outstanding shares.
Key Events
-
Major Stake Sale Consummated
Novonor S.A. (under judicial reorganization) has completed the sale of its 34.3% stake in Braskem (50.1% of voting capital) to Shine I Fundo de Investimento.
-
New Shareholders' Agreement in Effect
The previously disclosed Shareholders' Agreement between Shine I Fundo de Investimento and Petrobras S.A. has now entered into full force and effect, formalizing shared control.
-
Mandatory Tender Offer Announced
Shine I Fundo de Investimento will submit a request for registration of a public offering to acquire up to all of Braskem's outstanding common and preferred shares.
-
Upcoming Governance Changes
An Extraordinary General Meeting is scheduled for June 8, 2026, to approve new bylaws, elect a new Board of Directors, and replace Fiscal Council members.
Analysis
This filing confirms the closing of a critical ownership transfer, where Novonor S.A. (under judicial reorganization) sold a significant 34.3% stake in Braskem (representing 50.1% of voting capital) to Shine I Fundo de Investimento. This consummation resolves a major ownership uncertainty for a company that has recently reported substantial losses and was considering judicial reorganization. The new Shareholders' Agreement between Shine I Fund and Petrobras is now in effect, and Shine I Fund will launch a tender offer for all outstanding shares, fundamentally reshaping Braskem's control and governance structure. An Extraordinary General Meeting is scheduled for June 8, 2026, to elect a new Board of Directors and reform the company's bylaws.
At the time of this filing, BAK was trading at $3.73 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.32 to $5.40. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.